Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. Implanet SA
  6. News
  7. Summary
    ALIMP   FR0013470168

IMPLANET SA

(ALIMP)
  Report
Real-time Euronext Paris  -  11:00 2022-08-05 am EDT
0.1688 EUR   -0.71%
07/11Implanet S.A. Reports Revenue for the Second Quarter and First Half of 2022
CI
06/29Implanet Announces A Commercial, Technological and Financial Partnership with Sanyou Medical
CI
04/19Implanet S.A. Announces Consolidated Revenue Results for the First Quarter of 2022
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Implanet S.A. Reports Earnings Results for the Full Year Ended December 31, 2021

03/15/2022 | 12:00pm EDT
share with twitter
share with LinkedIn
share with facebook

Implanet S.A. reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was EUR 6.14 million compared to EUR 3.89 million a year ago. Net loss was EUR 3.09 million compared to EUR 3.98 million a year ago.


© S&P Capital IQ 2022
All news about IMPLANET SA
07/11Implanet S.A. Reports Revenue for the Second Quarter and First Half of 2022
CI
06/29Implanet Announces A Commercial, Technological and Financial Partnership with Sanyou Me..
CI
04/19Implanet S.A. Announces Consolidated Revenue Results for the First Quarter of 2022
CI
04/19IMPLANET : reports Q1 2022 revenue
PU
04/19IMPLANET SA : 1st quarter earnings
CO
03/15Implanet S.A. Reports Earnings Results for the Full Year Ended December 31, 2021
CI
03/15IMPLANET SA : Annual results
CO
02/09IMPLANET Announces the First Surgical Procedures in the United States with JAZZ PF
CI
01/18IMPLANET : Inside Information / Information on annual revenues
PU
01/18Implanet S.A. Reports Revenue Results for the Fourth Quarter and Full Year Ended Decemb..
CI
More news
Financials
Sales 2022 9,30 M 9,45 M 9,45 M
Net income 2022 - - -
Net Debt 2022 - - -
P/E ratio 2022 -
Yield 2022 -
Capitalization 2,50 M 2,54 M 2,54 M
Capi. / Sales 2022 0,27x
Capi. / Sales 2023 0,23x
Nbr of Employees 39
Free-Float 58,0%
Chart IMPLANET SA
Duration : Period :
Implanet SA Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends IMPLANET SA
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 1
Last Close Price 0,17 €
Average target price 1,86 €
Spread / Average Target 1 002%
Managers and Directors
Ludovic Lastennet CEO, Director & Commercial Director
David Dieumegard Vice President-Finance
Jean-Gérard Galvez Chairman
Régis Le Couëdic Vice President-Research & Development
Yvanna Peigné Operations Manager
Sector and Competitors
1st jan.Capi. (M$)
IMPLANET SA-45.11%3
STRYKER CORPORATION-19.31%81 638
SMITH & NEPHEW PLC-17.24%11 235
INSPIRE MEDICAL SYSTEMS, INC.-5.46%6 011
AXONICS, INC.26.79%3 488
GLAUKOS CORPORATION19.22%2 520